InMode (INMD) Total Non-Current Liabilities (2018 - 2026)

InMode (INMD) posted quarterly Total Non-Current Liabilities of $12.2 million for Q1 2026, down 3.3% year-on-year from $12.6 million in Q1 2025, and down 2.05% on a QoQ basis from $12.5 million in Q4 2025.

InMode (INMD) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

InMode (INMD) has reported Total Non-Current Liabilities for 9 consecutive years, with $12.2 million the latest figure, recorded in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 3.3% year-over-year to $12.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.2 million (down 3.3% YoY) and the FY2025 annual result came in at $12.5 million, up 4.03% from the prior year.
  • Total Non-Current Liabilities fell to $12.2 million in Q1 2026 per INMD's latest filing, from $12.5 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for INMD reached as high as $13.4 million in Q2 2025 and fell as low as $7.0 million in Q1 2023.
  • A 5-year average of $11.0 million and a median of $11.8 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 64.94% — and 2023, when it tumbled 42.0%.
  • Year by year, Total Non-Current Liabilities stood at $7.8 million in 2022, then surged by 51.56% to $11.8 million in 2023, then rose by 1.91% to $12.0 million in 2024, then advanced by 4.03% to $12.5 million in 2025, then decreased by 2.05% to $12.2 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $12.2 million, $12.5 million, and $12.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 InMode 956,721.10 -479.17 Mn 61.55 Mn 12.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.23 Mn
Dec 31, 2025 12.49 Mn
Sep 30, 2025 12.89 Mn
Jun 30, 2025 13.38 Mn
Mar 31, 2025 12.65 Mn
Dec 31, 2024 12.00 Mn
Sep 30, 2024 11.44 Mn
Jun 30, 2024 11.03 Mn
Mar 31, 2024 11.31 Mn
Dec 31, 2023 11.78 Mn
Sep 30, 2023 7.85 Mn
Jun 30, 2023 7.19 Mn
Mar 31, 2023 6.96 Mn
Dec 31, 2022 7.77 Mn
Sep 30, 2022 12.75 Mn
Jun 30, 2022 12.40 Mn
Mar 31, 2022 11.33 Mn
Dec 31, 2021 10.89 Mn
Sep 30, 2021 9.76 Mn
Jun 30, 2021 9.68 Mn